聊天GPT模型的优点和弱点 关于医学的科学写作 维生素B12:混合方法研究研究
1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, 13133, Jordan.
JMIR formative research
|November 10, 2023
概括
与GPT-3.5相比,GPT-4表现出了比GPT-3.5更好的科学内容生成,有助于执行诸如抽象写作等任务. 然而,偏见检测,最新信息和引用的局限性需要科学家仔细监督.
科学领域:
- 科学研究中的人工智能
- 自然语言处理应用程序
背景情况:
- 由OpenAI开发的大型语言模型ChatGPT生成类似人类的文本.
- 评估人工智能在科学内容创建中的作用至关重要.
研究的目的:
- 评估GPT-4的科学内容生成能力.
- 将GPT-4的性能与GPT-3.5进行比较,用于科学写作.
- 使用维生素B12作为一个特定的医疗主题进行评估.
主要方法:
- 从GPT-4和GPT-3.5产生对维生素B12提示的反应.
- 分析了人工智能生成内容的质量和特征.
- 与已建立的科学文献比较AI输出.
主要成果:
- GPT-4在简化编辑和抽象生成等科学写作任务方面显示出潜力.
- 与GPT-3.5.5相比,GPT-4具有更高的准确性.
- 确定的局限性包括偏见检测,过时的信息,缺乏透明度,不准确性,无法提供参考或检查抄袭.
结论:
- 聊天GPT作为一个有价值的写作助手,但不能取代科学专业知识.
- 研究人员必须意识到人工智能的局限性,并明智地使用工具.
- 未来的ChatGPT版本可能会克服当前的限制.
相关概念视频
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Pharmacokinetic Models: Overview
720
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
720
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K


